Optochemogenetics could improve lifespan

Researchers at Emory University activate stem cells with a new technique called ‘optochemogenetics’ to help stroke recovery.

As stem cells can become any cell in the brain and repair some brain damage, researchers see this as the key to helping stroke patients to repair neural cells and prevent long-term damage. A stroke is a blockage in the blood which, due to restricted blood flow, stops essential oxygen and nutrients from reaching the cells in the brain. This causes brain damage as the cells become starved of oxygen and become damaged or die, the consequences of this can last from several minutes to a lifetime, depending on how long the block remains.

Longevity.Technology: Stem cell therapy for strokes is a recent breakthrough as researchers found that stem cells had the ability to kick-start the cell-regenerating process in the brain. Researchers at Emory University took this concept one step further and developed a new technique called optochemogenetics [1].

The TRL score for this Longevity.Technology domain is currently set at: ‘Principles are demonstrated through experimentation.’


The TRL score for the technology addressed in this article is: ‘Early proof of concept demonstrated in the laboratory.’

Published in the Journal of Neuroscience, Ling Wei, Shang Ping Yu, and his colleagues worked on a clinical study with mice, which consisted of injecting neural stem cells into the mice after a stroke. The cells were then stimulated by the administration of a protein through the nasal cavity [2].

Results showed that once the cells were activated, they were found to have made more neural connections and were healthier than they were prior to the treatment. The mouse models showed the highest recovery rates when the mice received both the injection of stem cells and the new optochemogenetics technique of stem cell activation. They discovered that they even displayed some of the same behavioural patterns as they did prior to the stroke.

However, as the study’s results are based on mouse models, whether the results would be translatable to humans is still in question. Many mouse models that produce positive results in a laboratory often fail to reach the stage of a viable product ready for human use. Yet, if this new technique passes the hurdles of approval and efficacy testing, this novel technique of activating stem cells may be the beginning of vastly improving the recovery of stroke victims and may become applicable to creating treatments for many other types of diseases that cause cell damage.

[1] https://www.sciencedaily.com/releases/2019/07/190701144313.htm
[2] https://www.jneurosci.org/content/early/2019/07/01/JNEUROSCI.2010-18.2019


Salvinija Roznyte
Staff Writer Salvinija Roznyte is a writer and journalist based in London. She graduated in 2018 with a Bachelor's degree majoring in Writing and Journalism with a minor in Film Studies. She is interested in the way modern medical technology changes and shapes our world.

Latest articles

eGenesis’ xenotransplantation trials move closer to in-human

eGenesis' groundbreaking xenotransplantation work with Massachusetts General Hospital to be expanded through additional collaboration. eGenesis has announced it is expanding its research collaboration with the...

New Japanese stem cell clinical trial for aging frailty

Longeveron announces Phase 2 clinical trial to evaluate the safety and efficacy of Mesenchymal Stem Cells (LMSCs) for the treatment of aging frailty in...

Unlocking the Longevity potential of our oceans

Biologist focuses on the coast of Oman to discover how extreme environments and oceanic life could provide sources for Longevity. With issues like climate change, overfishing...

Alkahest announces phase 2 study treatment of cognitive impairment

Extra-corporeal medical device could improve neuro outlook for end-stage renal disease patients. Alkahest has announced its first foray into dialysis-associated dementia with a new randomised,...